APA (7th ed.) Citation

Utama, S., Cale, J. M., Mitrpant, C., Fletcher, S., Wilton, S. D., & Aung-Htut, M. T. (2024). Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers–Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15? International Journal of Molecular Sciences, 25(16), 8816. https://doi.org/10.3390/ijms25168816

Chicago Style (17th ed.) Citation

Utama, Sasiwimon, Jessica M. Cale, Chalermchai Mitrpant, Sue Fletcher, Steve D. Wilton, and May T. Aung-Htut. "Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers–Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15?" International Journal of Molecular Sciences 25, no. 16 (2024): 8816. https://doi.org/10.3390/ijms25168816.

MLA (9th ed.) Citation

Utama, Sasiwimon, et al. "Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers–Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15?" International Journal of Molecular Sciences, vol. 25, no. 16, 2024, p. 8816, https://doi.org/10.3390/ijms25168816.